SCHEMBL14788456

SCHEMBL14788456

C#CC(=O)N(c1cccc(C(F)(F)F)c1)C(C(=O)NC1CCCC1)c1cccs1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.48
▸ USP2 O75604 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ PRNP P04156 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ MAPT P10636 5/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ THRB P10828 1/20 0.46
▸ ALOX12 P18054 1/20 0.46
▸ NPSR1 Q6W5P4 2/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12639366 0.99 ALDH1A1 (0.49) ALDH1A1USP2TSHRMAPK1PRNP
SCHEMBL12639363 0.90 SMN1; SMN2 (0.52) ALDH1A1USP2TSHRMAPK1PRNP
SCHEMBL12639393 0.90 MAPT (0.48) ALDH1A1USP2TSHRMAPK1PRNP
SCHEMBL12672203 0.88 MAPT (0.51) ALDH1A1USP2TSHRMAPK1PRNP
SCHEMBL1888032 0.88 CYP1A2 (0.51) ALDH1A1USP2TSHRMAPK1PRNP
SCHEMBL1567018 0.87 MAPT (0.48) ALDH1A1USP2TSHRMAPK1PRNP
SCHEMBL14788382 0.87 ALDH1A1 (0.51) ALDH1A1USP2TSHRMAPK1PRNP
SCHEMBL12672209 0.86 TDP1 (0.54) ALDH1A1USP2TSHRMAPK1PRNP
SCHEMBL15189209 0.86 MAPT (0.54) ALDH1A1USP2TSHRMAPK1PRNP
SCHEMBL1568589 0.86 MAPT (0.54) ALDH1A1USP2TSHRMAPK1PRNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130071328-A1 Propynoic Acid Carbamoyl Methyl-Amides and Pharmaceutical Compositions and Methods Based Thereon UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2013-03-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130071328-A1 Propynoic Acid Carbamoyl Methyl-Amides and Pharmaceutical Compositions and Methods Based Thereon RELA, NFE2, NCOA1 ALDH1A1 1558/4885USP2 1440/4885TSHR 4511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback